Physical Activity, Alzheimer Plasma Biomarkers, and Cognition
JAMA Network Open · 05.03.2025 · 8 (3) · e250096
DOI: 10.1001/jamanetworkopen.2025.0096 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 05.03.2025. Verfasst von Seung Ae Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Hospital, Seoul, South Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Exercise, Cognition. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Importance Physical activity (PA) is a nonpharmacological intervention for dementia prevention. The association between PA and Alzheimer disease (AD) plasma biomarkers remains underexplored.
Objective
To investigate the associations among PA; plasma biomarkers, including β-amyloid 42/40 (Aβ42/40), phosphorylated-tau217 (ptau217), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL); and cognition. Design, Setting, and Participants This cross-sectional study included participants with and without cognitive impairment recruited from multiple memory clinics in South Korea between May 2019 and May 2022. Data were analyzed from June to December 2024. Exposures PA was assessed as metabolic equivalent task minutes per week using the International Physical Activity Questionnaire and categorized into quartiles from the lowest (Q1) to the highest (Q4). Main Outcomes and Measures Plasma Aβ42/40, ptau217, GFAP, and NfL were measured. Cognition was assessed using the Mini-Mental State Examination (MMSE) and Clinical Dementia Rating-Sum of Boxes (CDR-SB).
Results
Among 1144 participants (mean [SD] age 70.9 [8.7] years; 744 [65.0%] female), the highest PA quartile showed significantly lower ptau217 (estimate [SE], −0.14 [0.06]; P = .01) and NfL (estimate [SE], −0.12 [0.05]; P = .01) compared with the lowest quartile. Higher PA quartiles were associated with higher MMSE scores (estimate [SE]: Q2, 0.93 [0.31]; P = .003; Q3, 0.82 [0.32]; P = .009; Q4, 0.94 [0.32]; P = .004) and lower CDR-SB scores (estimate [SE]: Q2, –0.33 [0.16]; P = .04; Q3, –0.37 [0.16]; P = .02; Q4, –0.55 [0.16]; P = .001) after adjusting for age, sex, education years, and β-amyloid uptake. In subgroup analyses according to age and cognitive status, the associations of PA and plasma biomarkers with cognition were more pronounced in the older (age ≥65 years) and cognitively impaired groups compared with the younger and cognitively unimpaired groups. Conclusions and Relevance These findings suggest that PA may help delay cognitive decline by modulating neurodegeneration and AD-specific tau pathologies. However, the cross-sectional design limits causal inference, and longitudinal studies are needed to confirm and clarify these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University Hospital, Seoul, South Korea.
- Seoul National University College of Medicine, Seoul, South Korea.
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, South Korea.
- Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea.
- Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.
- Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, South Korea.
Zitieren
APA
Kim, S. A., Shin, D., Ham, H., Kim, Y., Gu, Y., Kim, H. J., Na, D. L., Zetterberg, H., Blennow, K., Seo, S. W., Jang, H., & Precision Medicine Platform for Mild Cognitive Impairment Based on Multi-omics, Imaging, Evidence-Based R&BD (PREMIER) Consortium (2025). Physical Activity, Alzheimer Plasma Biomarkers, and Cognition. JAMA Network Open, 8(3), e250096. https://doi.org/10.1001/jamanetworkopen.2025.0096
Vancouver
Kim SA, Shin D, Ham H, Kim Y, Gu Y, Kim HJ, et al. Physical Activity, Alzheimer Plasma Biomarkers, and Cognition. JAMA Network Open. 2025;8(3):e250096. doi:10.1001/jamanetworkopen.2025.0096
BibTeX
@article{Kim2025,
author = {Kim, Seung Ae and Shin, Daeun and Ham, Hongki and Kim, Yeshin and Gu, Yuna and Kim, Hee Jin and Na, Duk L and Zetterberg, Henrik and Blennow, Kaj and Seo, Sang Won and Jang, Hyemin and Precision Medicine Platform for Mild Cognitive Impairment Based on Multi-omics, Imaging, Evidence-Based R&BD (PREMIER) Consortium, Precision Medicine Platform for Mild Cognitive Impairment Based on Multi-omics, Imaging, Evidence-Based R&BD (PREMIER) Consortium},
title = {Physical Activity, Alzheimer Plasma Biomarkers, and Cognition},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {3},
pages = {e250096},
doi = {10.1001/jamanetworkopen.2025.0096}
}
EUVIMED